CALL - SPRINTER OPEN END - STRYKER CORP. Share Price

Certificat

DE000VM55GQ3

Delayed Deutsche Boerse AG 11:22:34 26/06/2024 pm IST
3.98 EUR +6.70% Intraday chart for CALL - SPRINTER OPEN END - STRYKER CORP.
Current month-2.69%
1 month+7.57%
Date Price Change
26/24/26 3.98 +6.70%
25/24/25 3.73 -9.69%
24/24/24 4.13 +2.48%
21/24/21 4.03 -1.47%
20/24/20 4.09 -18.85%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 11:22 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55GQ
ISINDE000VM55GQ3
Date issued 29/11/2023
Strike 298.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.3
Lowest since issue 0.135
Spread 0.35
Spread %8.43%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.52%
Consensus